Evidence map›Paper›PMID 29862267›Full record

ArticleBioMed research international2018

PPAR

Yong Gao, Dongfeng Han, Laisheng Sun, Qihua Huang, Guangchao Gai, Zicheng Wu, Wei Meng, Xincheng Chen

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ubiquitin ligaseOncology letters · 2019
    Article
  14. PPAR-PPAR research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yong GaoDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Dongfeng HanDepartment of Neurosurgery, Xuzhou Central Hospital, 199 Jie Fang Nan Road, Xuzhou 221009, China.
Laisheng SunDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Qihua HuangDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Guangchao GaiDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Zicheng WuDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Wei MengDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.
Xincheng ChenDepartment of Neurosurgery, Xinyi People's Hospital, Xinyi, Jiangsu, China.ORCID 0000-0001-9376-1172
Xintai People's Hospital · CNXuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor

Indexed as

G1 Phase Cell Cycle CheckpointsResting Phase, Cell CycleCell Line, TumorE2F2 Transcription FactorGliomaHumansMicroRNAsNeoplasm ProteinsPPAR alphaRNA, NeoplasmE2F2 protein, humanE2F2 Transcription FactorMicroRNAsMIRN214 microRNA, humanNeoplasm ProteinsPPAR alphaRNA, Neoplasm

Identifiers

PMID29862267
PMCPMC5976971
OpenAlexW2801526660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.